Ka. Duggan et Vzc. Ye, EFFECTS OF ENALAPRIL ON VASOACTIVE-INTESTINAL-PEPTIDE METABOLISM AND TISSUE-LEVELS, European journal of pharmacology, 358(1), 1998, pp. 25-30
Angiotensin converting enzyme inhibitor therapy results in an increase
in cardiac output without an increase in heart rate suggesting a posi
tive inotropic effect. This cannot be explained by changes in angioten
sin II and bradykinin concentrations. Angiotensin converting enzyme ma
y also metabolise vasoactive intestinal peptide (VIP), a vasodilator a
nd positive inotrope whose concentration in the heart declines in hear
t failure. We sought to determine whether changes in plasma VIP or its
metabolism might explain the positive inotropic effect of angiotensin
converting enzyme inhibitors. We also measured VIP in the heart to de
termine whether a local increase in VIP might explain this effect. Mal
e Sprague-Dawley rats were randomised to control and enalapril groups
(2 mg kg(-1) day(-1)). After 7 days, rats were anaesthetised and under
went metabolic clearance studies for VIP or had hearts, lungs and kidn
eys removed and snap frozen. VIP concentrations in plasma, infusate an
d tissue extracts were measured by radioimmunoassay. Plasma concentrat
ions of VIP were unchanged by treatment with enalapril (control: 7.7 /- 0.8 pmol l(-1); enalapril: 7.9 +/- 0.8 pmol l(-1)), while the metab
olic clearance rate of VIP increased significantly (control: 10.4 +/-
1.4 ml min(-1) 100 g(-1); enalapril: 17.3 +/- 1.6 mi min(-1) 100 g(-1)
; P < 0.005) Secretion rate also increased in enalapril treated rats (
139.1 +/- 25.0 pmol min(-1) 100 g(-1)) compared with controls (96.3 +/
- 13.4 pmol min(-1) 100 g(-1); P < 0.01). VIP in the heart increased a
fter enalapril (control: 208.4 +/- 39.0 pmol g(-1); enalapril: 928.9 /- 123.6 fmol g(-1); P < 0.0005). Angiotensin converting enzyme inhibi
tion increases the metabolism of VIP, However, the significant increas
e in the myocardial concentration of VIP may contribute to the benefic
ial haemodynamic inotrope effects of angiotensin converting enzyme inh
ibitors. (C) 1998 Elsevier Science B.V. All rights reserved.